Class information for:
Level 1: SECONDARY HYPERPARATHYROIDISM//RENAL OSTEODYSTROPHY//LANTHANUM CARBONATE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
469 3344 35.8 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
383 16378 PRIMARY HYPERPARATHYROIDISM//HYPERPARATHYROIDISM//SECONDARY HYPERPARATHYROIDISM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SECONDARY HYPERPARATHYROIDISM Author keyword 288 45% 14% 477
2 RENAL OSTEODYSTROPHY Author keyword 204 51% 9% 290
3 LANTHANUM CARBONATE Author keyword 178 82% 3% 104
4 PHOSPHATE BINDER Author keyword 164 75% 4% 119
5 SEVELAMER HYDROCHLORIDE Author keyword 148 87% 2% 73
6 HYPERPHOSPHATEMIA Author keyword 136 43% 7% 239
7 PHOSPHATE BINDERS Author keyword 115 64% 3% 114
8 SEVELAMER Author keyword 107 71% 3% 86
9 ADYNAMIC BONE DISEASE Author keyword 78 71% 2% 63
10 CINACALCET Author keyword 60 45% 3% 102

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SECONDARY HYPERPARATHYROIDISM 288 45% 14% 477 Search SECONDARY+HYPERPARATHYROIDISM Search SECONDARY+HYPERPARATHYROIDISM
2 RENAL OSTEODYSTROPHY 204 51% 9% 290 Search RENAL+OSTEODYSTROPHY Search RENAL+OSTEODYSTROPHY
3 LANTHANUM CARBONATE 178 82% 3% 104 Search LANTHANUM+CARBONATE Search LANTHANUM+CARBONATE
4 PHOSPHATE BINDER 164 75% 4% 119 Search PHOSPHATE+BINDER Search PHOSPHATE+BINDER
5 SEVELAMER HYDROCHLORIDE 148 87% 2% 73 Search SEVELAMER+HYDROCHLORIDE Search SEVELAMER+HYDROCHLORIDE
6 HYPERPHOSPHATEMIA 136 43% 7% 239 Search HYPERPHOSPHATEMIA Search HYPERPHOSPHATEMIA
7 PHOSPHATE BINDERS 115 64% 3% 114 Search PHOSPHATE+BINDERS Search PHOSPHATE+BINDERS
8 SEVELAMER 107 71% 3% 86 Search SEVELAMER Search SEVELAMER
9 ADYNAMIC BONE DISEASE 78 71% 2% 63 Search ADYNAMIC+BONE+DISEASE Search ADYNAMIC+BONE+DISEASE
10 CINACALCET 60 45% 3% 102 Search CINACALCET Search CINACALCET

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SECONDARY HYPERPARATHYROIDISM 264 28% 24% 801
2 PHOSPHATE BINDER 166 70% 4% 138
3 OSTEODYSTROPHY 151 45% 8% 252
4 SEVELAMER HYDROCHLORIDE 135 67% 4% 120
5 INTRAVENOUS CALCITRIOL 129 66% 4% 119
6 HYPERPHOSPHATEMIA 129 43% 7% 229
7 FREE PHOSPHATE BINDER 114 80% 2% 70
8 ADYNAMIC BONE 113 84% 2% 62
9 LANTHANUM CARBONATE 109 70% 3% 90
10 SERUM PHOSPHORUS 101 48% 5% 155

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 THERAPEUTIC APHERESIS AND DIALYSIS 12 11% 3% 107
2 ITALIAN JOURNAL OF MINERAL & ELECTROLYTE METABOLISM 3 15% 1% 17

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney disease: Improving global outcomes (KDIGO) 2006 593 29 52%
Drug Therapy: Oral Phosphate Binders in Patients with Kidney Failure. 2010 118 89 82%
Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease A Systematic Review and Meta-analysis 2011 175 66 52%
Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options 2011 67 72 63%
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference 2015 1 19 63%
Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease 2010 71 45 44%
Meta-analysis: Vitamin D compounds in chronic kidney disease 2007 114 92 71%
Use of phosphate binders in chronic kidney disease 2013 10 41 76%
Hyperphosphatemia The hidden killer in chronic kidney disease 2015 1 46 50%
Oral phosphate binders 2009 42 78 69%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEPHROL BONE MINERAL METAB 15 36% 1.0% 33
2 NEPHROL ENDOCRINOL METAB 12 36% 0.8% 26
3 BLOOD PURIFICAT THER Y 11 43% 0.6% 20
4 MINERVA CALCIUM BONE METAB 9 40% 0.5% 17
5 CHROMALLOY AMER KIDNEY 8 75% 0.2% 6
6 NEPHROL BLOOD PURIFICAT MED 7 41% 0.4% 13
7 REINA SOFIA INVEST 6 26% 0.6% 21
8 SERV METAB OSEO MINERAL 5 32% 0.4% 12
9 CLIN LANDY 4 75% 0.1% 3
10 INTERNE ABT NEPHROL 4 75% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000183344 PTH ASSAYS//WHOLE PTH//INTACT PTH
2 0.0000148292 VASCULAR CALCIFICATION//MATRIX GLA PROTEIN//KEUTEL SYNDROME
3 0.0000112352 POST TRANSPLANTATION BONE DISEASE//POSTTRANSPLANTATION BONE DISEASE//PERSISTENT HYPERPARATHYROIDISM
4 0.0000081461 CALCIUM SENSING RECEPTOR//FAMILIAL HYPOCALCIURIC HYPERCALCEMIA//CASR
5 0.0000077479 FGF 23//KLOTHO//FIBROBLAST GROWTH FACTOR 23
6 0.0000077310 VITAMIN D//VITAMIN D DEFICIENCY//PARICALCITOL
7 0.0000076057 PHOSPHATE DEPLETION//CA DYNAMICS//CADAVERIC RENAL ALLOGRAFT
8 0.0000069872 PARATHYROID GLAND//LARGE VACUOLAR BODY//WATER CLEAR CELL
9 0.0000052493 ALUMINUM EXPOSURE//INVEST FISIOL EXPT//DIALYSIS ENCEPHALOPATHY
10 0.0000052480 BENZARONE//BENZBROMARONE//EQUATORIAL CONFORMATION